{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:57Z","timestamp":1793155737497,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00428-015-1796-6","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T10:29:01Z","timestamp":1434623341000},"page":"345-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas"],"prefix":"10.1007","volume":"467","author":[{"given":"D\u00f3ra","family":"Kren\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita","family":"Borb\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Bedekovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"M\u00e9hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151","family":"Bagdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Kren\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"1796_CR1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1101\/gad.6.9.1783","volume":"6","author":"YT Yu","year":"1992","unstructured":"Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B (1992) Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev 6:1783\u20131798. doi: 10.1101\/gad.6.9.1783","journal-title":"Genes Dev"},{"key":"1796_CR2","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/MCB.13.4.2564","volume":"13","author":"McDermott JC","year":"1993","unstructured":"JC MD, Cardoso MC, Yu Y-T, et al (1993) hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol 13:2564\u20132577","journal-title":"Mol Cell Biol"},{"key":"1796_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/dbio.1995.0002","volume":"172","author":"EN Olson","year":"1995","unstructured":"Olson EN, Perry M, Schulz RA (1995) Regulation of muscle differentiation by the MEF1 family of MADS box transcription factors. Dev Biol 172:2\u201314. doi: 10.1006\/dbio.1995.0002","journal-title":"Dev Biol"},{"key":"1796_CR4","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","volume":"134","author":"MJ Potthoff","year":"2007","unstructured":"Potthoff MJ, Olson EN (2007) MEF2: a central regulator of diverse developmental programs. Development 134:4131\u20134140. doi: 10.1242\/dev.008367","journal-title":"Development"},{"key":"1796_CR5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.286.5440.785","volume":"286","author":"Z Mao","year":"1999","unstructured":"Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME (1999) Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785\u2013790. doi: 10.1126\/science.286.5440.785","journal-title":"Science"},{"key":"1796_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.cellbio.14.1.167","volume":"14","author":"BL Black","year":"1998","unstructured":"Black BL, Olson EN (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14:167\u2013196. doi: 10.1146\/annurev.cellbio.14.1.167","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1796_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0968-0004(01)02031-X","volume":"27","author":"McKinsey TA","year":"2002","unstructured":"TA MK, Zhang CL, Olson EN (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27:40\u201347","journal-title":"Trends Biochem Sci"},{"key":"1796_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nature01555","volume":"422","author":"A Han","year":"2003","unstructured":"Han A, Pan F, Stroud JC, Youn HD, Liu JO, Chen L (2003) Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature 422:730\u2013734. doi: 10.1038\/nature01555","journal-title":"Nature"},{"key":"1796_CR9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/emboj\/16.8.1865","volume":"16","author":"LE Cheng","year":"1997","unstructured":"Cheng LE, Chan FK, Cado D, Winoto A (1997) Functional redundancy of the Nur77 and Nor-1orphan steroid receptors in T-cell apoptosis. EMBO J 16:1865\u20131875. doi: 10.1093\/emboj\/16.8.1865","journal-title":"EMBO J"},{"key":"1796_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0161-5890(98)00058-3","volume":"35","author":"BJ Swanson","year":"1998","unstructured":"Swanson BJ, Jack HM, Lyons GE (1998) Characterization of myocyte enhancer binding factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell restricted transcription factor in lymphocytes. Mol Immun. 35:445\u2013458","journal-title":"Mol Immun."},{"key":"1796_CR11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.286.5440.790","volume":"286","author":"HD Youn","year":"1999","unstructured":"Youn HD, Sun L, Prywes R, Liu JO (1999) Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286:790\u2013793. doi: 10.1126\/science.286.5440.790","journal-title":"Science"},{"key":"1796_CR12","doi-asserted-by":"crossref","first-page":"17067","DOI":"10.1073\/pnas.0804868105","volume":"105","author":"D Khiem","year":"2008","unstructured":"Khiem D, Cyster JG, Schwarz JJ, Black BL (2008) A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc Natl Acad Sci U S A 105:17067\u201317072. doi: 10.1073\/pnas.0804868105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1796_CR13","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/MCB.16.7.3814","volume":"16","author":"JD Molkentin","year":"1996","unstructured":"Molkentin JD, Firulli AB, Black BL, et al. (1996) MEF2B is a potent transactivator expressed in early myogenic lineages. Mol Cell Biol 16:3814\u20133824","journal-title":"Mol Cell Biol"},{"key":"1796_CR14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","volume":"14","author":"CY Ying","year":"2013","unstructured":"Ying CY, Dominguez-Sola D, Fabi M, et al (2013) MEF2B mutations lead to deregulated expression of the oncogene bcl-6 in diffuse large B cell lymphoma. Nat Immunol 14:1084\u20131092. doi: 10.1038\/ni.2688","journal-title":"Nat Immunol"},{"key":"1796_CR15","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon","edition":"4th"},{"key":"1796_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner T, et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282. doi: 10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"1796_CR17","first-page":"220","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"NL Harris","year":"2008","unstructured":"Harris NL, Swerdlow SH, Jaffe ES, et al (2008) Follicular lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 220\u2013226","edition":"4th"},{"key":"1796_CR18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/B6MK-J7NF-A6JP-X56K","volume":"115","author":"C Eshoa","year":"2001","unstructured":"Eshoa C, Perkins S, Kampalath B, Shidham V, Juckett M, Chang CC (2001) Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. Am J Clin Pathol 115:862\u2013867","journal-title":"Am J Clin Pathol"},{"key":"1796_CR19","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","volume":"99","author":"G Ott","year":"2002","unstructured":"Ott G, Katzenberger T, Lohr A, et al (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 99:3806\u20133812. doi: 10.1182\/blood.V99.10.3806","journal-title":"Blood"},{"key":"1796_CR20","first-page":"227","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"R Willemze","year":"2008","unstructured":"Willemze R, Swerdlow SH, Harris NL, Vergier B (2008) Primary cutaneous follicle centre lymphoma. Follicular lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 227\u2013228","edition":"4th"},{"key":"1796_CR21","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood.V91.12.4708","volume":"91","author":"A Dogan","year":"1998","unstructured":"Dogan A, Du DQ, Aiello A, et al (1998) Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 91:4708\u20134714","journal-title":"Blood"},{"key":"1796_CR22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","volume":"34","author":"SF Younes","year":"2010","unstructured":"Younes SF, Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y (2010) Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components. Am J Surg Pathol 34:1266\u20131276. doi: 10.1097\/PAS.0b013e3181e9343d","journal-title":"Am J Surg Pathol"},{"key":"1796_CR23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","volume":"113","author":"T Katzenberger","year":"2009","unstructured":"Katzenberger T, Kalla J, Leich E, et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113:1053\u20131061. doi: 10.1182\/blood-2008-07-168682","journal-title":"Blood"},{"key":"1796_CR24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1309\/W3QX-WJ1C-WG2K-225V","volume":"117","author":"RB West","year":"2002","unstructured":"West RB, Warnke RA, Natkunaam Y (2002) The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. Am J Clin Pathol 117:636\u2013643","journal-title":"Am J Clin Pathol"},{"key":"1796_CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1309\/AJCP7Z2BIBUNQPLZ","volume":"135","author":"SF Younes","year":"2011","unstructured":"Younes SF, Beck AH, Ohgami RS, et al (2011) The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow. Am J Clin Pathol 135:697\u2013708. doi: 10.1309\/AJCP7Z2BIBUNQPLZ","journal-title":"Am J Clin Pathol"},{"key":"1796_CR26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298\u2013303. doi: 10.1038\/nature10351","journal-title":"Nature"},{"key":"1796_CR27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks PM, Chan J, Cleary ML, et al (1992) Mantle cell lymphoma. A proposal for unification of morphologic, immologic, and molecular data. Am J Surg Pathol 16:637\u2013640","journal-title":"Am J Surg Pathol"},{"key":"1796_CR28","first-page":"229","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Seto M, M\u00fcller-Hermelink HK (2008) Mantle cell lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 229\u2013232","edition":"4th"},{"key":"1796_CR29","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea S, Valdes-Mas R, Navarro A, et al (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A 110:18250\u201318255. doi: 10.1073\/pnas.1314608110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1796_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2008.03060.x","volume":"53","author":"U Zanetto","year":"2008","unstructured":"Zanetto U, Dong H, Huang Y, et al (2008) Mantle cell lymphoma with aberrant expression of CD10. Histopathology 53:20\u201329. doi: 10.1111\/j.1365-2559.2008.03060.x","journal-title":"Histopathology"},{"key":"1796_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAI.0b013e3181bb9edf","volume":"18","author":"G Gualco","year":"2010","unstructured":"Gualco G, Weiss LM, Harrington Jr WJ, Bacchi CE (2010) BCL6, MUM1, and CD10 expression in mantle cell lymphoma. Appl Immunohistochem Mol Morphol 18:103\u2013108. doi: 10.1097\/PAI.0b013e3181bb9edf","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1796_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","volume":"61","author":"C Agostinelli","year":"2012","unstructured":"Agostinelli C, Paterson JC, Gupta R, et al (2012) Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Histopathology 61:33\u201346. doi: 10.1111\/j.1365-2559.2012.04198.x","journal-title":"Histopathology"},{"key":"1796_CR33","first-page":"185","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Piris MA, Berger F, et al (2008) Splenic B-cell marginal zone lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 185\u2013187","edition":"4th"},{"key":"1796_CR34","first-page":"214","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Chot A, Nakamura S, M\u00fcller-Hermelink HK, Harris NL, Swerdlow SH (2008) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma). In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 214\u2013217","edition":"4th"},{"key":"1796_CR35","doi-asserted-by":"crossref","unstructured":"Campo E, Pileri SA, Jaffe ES, M\u00fcller-Hermelink HK, Nathwani BN Nodal marginal zone lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon. pp 218\u2013219","DOI":"10.1097\/00000478-200002000-00035"},{"key":"1796_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","volume":"132","author":"ME Salama","year":"2009","unstructured":"Salama ME, Lossos IS, Warnke RA, Natkunam Y (2009) Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am J Clin Pathol 132:39\u201349. doi: 10.1309\/AJCPZQ1GXBBNG8OG","journal-title":"Am J Clin Pathol"},{"key":"1796_CR37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G, et al (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43:830\u2013837. doi: 10.1038\/ng.892","journal-title":"Nat Genet"},{"key":"1796_CR38","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","volume":"109","author":"JG Lohr","year":"2012","unstructured":"Lohr JG, Stojanov P, Lawrence MS, et al (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 109:3879\u20133884. doi: 10.1073\/pnas.1121343109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1796_CR39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","volume":"110","author":"J Zhang","year":"2013","unstructured":"Zhang J, Grubor V, Love CL, et al (2013) Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 110:1398\u20131403. doi: 10.1073\/pnas.1205299110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1796_CR40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","volume":"247","author":"K Basso","year":"2012","unstructured":"Basso K, Dalla-Favera R (2012) Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 247:172\u2013183. doi: 10.1111\/j.1600-065X.2012.01112.x","journal-title":"Immunol Rev"},{"key":"1796_CR41","first-page":"233","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2","author":"H Stein","year":"2008","unstructured":"Stein H, Warnke RA, Chan WC, et al (2008) Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, WHO classification of tumours, vol 2, 4th edn. IARC Press, Lyon, pp. 233\u2013237","edition":"4th"},{"key":"1796_CR42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511. doi: 10.1038\/35000501","journal-title":"Nature"},{"key":"1796_CR43","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC, et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15:5494\u20135502. doi: 10.1158\/1078-0432.CCR-09-0113","journal-title":"Clin Cancer Res"},{"key":"1796_CR44","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","volume":"94","author":"A Braeuninger","year":"1997","unstructured":"Braeuninger A, Kuppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML (1997) Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 94:9337\u20139342","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-015-1796-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1796-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T18:53:36Z","timestamp":1599159216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-015-1796-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1007\/s00428-015-1796-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]}}}